Anne M. Andrews, Ph.D.


Professor, Chemistry and Biochemistry

Organic Chemistry

Psychiatry and Biobehavioral Sciences

Physical Chemistry

Member, Biochemistry, Biophysics & Structural Biology GPB Home Area

Brain Research Institute


California NanoSystems Institute

Molecular Pharmacology GPB Home Area

Neuroscience GPB Home Area

Senior Research Scientist, Hatos Center for Neuropharmacology

Awards and Honors:

NIH Fellows Award for Research Excellence

United States Department of Education Fellowship

Phi Lambda Upsilon National Honorary Chemical Society Fellow

NIH Predoctoral Intramural Research Training Award

Eli Lilly Outstanding Analytical Chemist Award

NIH Postdoctoral Intramural Research Training Award

American Parkinson’s Disease Association Research Award

Sigma Xi, Scientific Research Society

NARSAD, Independent Investigator Award

American College of Neuropsychopharmacology Elected Fellow

Serotonin Club Councillor

Collegium Internationale Neuropsychopharmacologicum Fellow

ACS Chemical Neuroscience, American Chemical Society Associate Editor

Contact Information

Fax Number: 310-983-1133
Lab Number: 310-983-1126
Office Phone Number: 310-794-9421

Mailing Address:

Neuroscience Research Building
635 Charles E. Young Dr S, Box 957332
Los Angeles, CA 90095

Office Address:

Department of Psychiatry and Biobehavioral Sciences


Dr. Andrews is Richard Metzner Endowed Chair in Clinical Neuropharmacology, and Professor of Psychiatry & Biobehavioral Sciences and Chemistry & Biochemistry at the University of California, Los Angeles. She is a member of the Semel Institute for Neuroscience & Human Behavior, the Hatos Center for Neuropharmacology, and the California NanoSystems Institute. Dr. Andrews received her B.S. in Chemistry from the Pennsylvania State University and earned her Ph.D. in Chemistry as a U.S. Department of Education Fellow working at the National Institute of Mental Health, where she was later a postdoctoral fellow and senior staff fellow. At the NIMH, Andrews and her mentor, Dr. Dennis Murphy, discovered and characterized a novel serotonin neurotoxin, 2’-NH2-MPTP. Dr. Andrews was also instrumental in early studies on serotonin transporter deficient mice. Andrews is a member of the Society for Neuroscience, American Chemical Society, and Society for Electroanalytical Chemistry. She has been the recipient of an NIH Fellows Award for Research Excellence, an Eli Lily Outstanding Young Analytical Chemist Award, an American Parkinson’s Disease Association Research Award, and a NARSAD Independent Investigator Award. She is a elected member of the American College of Neuropsychopharmacology, a fellow of the Collegium Internationale Neuropsychopharmacologicum, and a Serotonin Club elected councilor. Dr. Andrews is also Associate Editor for ACS Chemical Neuroscience. At UCLA, Andrews leads efforts in basic and translational research on anxiety and depression, and at the nexus of nanoscience and neuroscience. Andrews’ interdisciplinary research team of neuroscientists, biologists, chemists, and engineers focuses on understanding how the serotonin system and particularly, the serotonin transporter, modulate neurotransmission to influence complex behaviors including anxiety, mood, stress responsiveness, and learning and memory. Genetic and pharmacologic mouse models and human gene variants are studied to understand the molecular basis of serotonin system function associated with the etiology and treatment of mood and anxiety disorders. Nanomaterials are designed for fundamental studies on neurotransmitter recognition by native and nonnative binding partners (aptamers) and for the development of in vivo nanobiosensors and functionally directed proteomics.